To determine the best experimental approach to generate CD8+ T cells specific for autologous NSCLC, a tumor cell line of the large cell carcinoma subtype was established from the surgical specimen of the CaPo13 NSCLC patient. The gene discussed is CD8A; the disease is neoplasm.